<DOC>
	<DOCNO>NCT03042130</DOCNO>
	<brief_summary>Patients congestive heart failure , grade 3-4 , addition standard care , randomize 1:1 . The study group receive 2 dos IV iron ( Iron carboxymaltose ) . The control group receive standard care alone . The study test effect additional IV iron symptom , clinical picture quality life treat patient .</brief_summary>
	<brief_title>Treatment With IV Iron Hospitalized Patients With Severe Heart Failure But Without Iron Deficiency</brief_title>
	<detailed_description>Patients congestive heart failure , grade 3-4 , addition standard care , randomize 1:1 . The study group receive 2 dos IV iron ( Iron carboxymaltose ) . The control group receive standard care alone . The study test effect additional IV iron symptom , clinical picture quality life treat patient . The parameter measure include clinical , lab , echo , quality life questionnaire .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Heart failure grade 34 Heart echo EF &lt; 40 % ( ejection fraction ) Hb &gt; 10 mg/dL Iron &gt; 50 mic/dL Iron/ transferrin rate &gt; 20 % Infection Acute ischemia Patients n't receive standard care 3 day investigational product administration Hemochromatosis Known allergy one product investigational product . Macrocytic anemia Iron excess Pregnant woman Mentally disable patient ca n't give concent properly .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>